Syndax Pharmaceuticals, Inc. (SNDX)
SNDX price $13.15 -0.10 -0.75%
- Ticker
- SNDX
- Price
- $13.15
- Change
- -0.10 -0.75%
- Market cap
- $1.17B
- P/E
- -5.22
- Forward P/E
- 37.45
- Sector
- Healthcare
- Industry
- Biotechnology
Syndax Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm focused on developing innovative therapies for cancer. Among its leading investigational products are SNDX-5613, currently undergoing Phase 1/2 clinical assessment, which targets the Menin-mixed lineage leukemia 1 protein interaction for treating MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML)…